AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
AstraZeneca PLC ADR rose 1.06% to $88.61, outperforming competitors in a grim trading session where NASDAQ fell 2.29% and Dow Jones fell 1.65%. It closed 0.79% below its 52-week high. Competitors Eli Lilly, Biogen, and Johnson & Johnson also saw gains. Trading volume was below average. Data compiled on November 13, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments